BridgeMD
New treatment option for Opioid Use Disorder
Official title Using AI and Peer Coaching to Address Racial Disparities Among People Who Use Opioids
ClinicalTrials.gov ID: NCT06569667
What this study is testing
- What it's testing
- Black and Latinx people who use opioids are disproportionately impacted by opioid overdose deaths. The proposed study assesses the efficacy of an open source, multimodal artificial intelligence-driven texting tool combined with peer recovery coach-supported text contact that delivers social services, stigma reduction, health habitus, and patient navigation content addressing social determinants of health to enhance receipt of buprenorphine in primary care among emergency department-enrolled Black / Latinx people who use opioids.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 99
You may be able to join if
- ≥18 years of age;
- fluent in English and/or Spanish;
- self-reported non-prescription opioid use \<30 days prior to consent;
- provision of informed consent;
- planned stay in NYC ≥12 month;
You likely can't join if
- inability to comprehend text content written at a 3rd grade reading level;
- physical or visual disability preventing mobile phone use;
- self-reported receipt of medications for OUD in past 30 days.
See the full eligibility criteria
- ≥18 years of age;
- fluent in English and/or Spanish;
- self-reported non-prescription opioid use \<30 days prior to consent;
- provision of informed consent;
- planned stay in NYC ≥12 month;
- self-identified Black and/or Latinx race/ethnicity;
- positive urine toxicology for opioids per EMR records;
- diagnosis of OUD per the Diagnostic and Statistical Manual of Mental Disorders-5
- self-reported interest in initiating buprenorphine in primary care
- must have a mobile phone data plan.
- inability to comprehend text content written at a 3rd grade reading level;
- physical or visual disability preventing mobile phone use;
- self-reported receipt of medications for OUD in past 30 days.
The study team makes the final eligibility decision.
Where it's taking place
- The Bronx, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 99 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include The Bronx, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.